Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Zsu-Zsu Chen, M.D.

Concepts (139)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Zsu-Zsu Chen's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Zsu-Zsu Chen has written about over time.
Cytosine, 1 publications between 2019 and 2019, average publication date October 2019. Genomics, 1 publications between 2020 and 2020, average publication date May 2020. Hypertrophy, Left Ventricular, 2 publications between 2021 and 2021, average publication date March 2021. Metabolome, 4 publications between 2019 and 2023, average publication date June 2021. Proteome, 4 publications between 2020 and 2022, average publication date July 2021. Diabetes Mellitus, Type 2, 7 publications between 2019 and 2024, average publication date December 2021. Metabolomics, 7 publications between 2021 and 2023, average publication date March 2022. Proteomics, 3 publications between 2022 and 2023, average publication date November 2022. Diabetes Mellitus, 2 publications between 2022 and 2023, average publication date December 2022. Blood Glucose, 3 publications between 2021 and 2024, average publication date February 2023. Oleic Acids, 1 publications between 2023 and 2023, average publication date April 2023. Hypoglycemic Agents, 3 publications between 2021 and 2024, average publication date July 2023. Metformin, 2 publications between 2024 and 2024, average publication date June 2024.

To see the data from this visualization as text, click here.
Chen's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (139)
Explore
_
Co-Authors (44)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.